MyEpiPen® Patient Support Program
Australia’s 35,000-member EpiClub® program has been revamped and rebranded by Viatris (formerly Mylan) as the MyEpiPen® Patient Support Program.
Benefits for patients who join MyEpiPen® include:
- Free EpiPen® trainer devices
- Email and SMS reminder service for patients before their EpiPen® adrenaline (epinephrine) Auto-Injector devices expire.
- ‘How to use’ cards to keep at home and share with others.
- Video explainers in 26 languages that are appropriate for new patients and as refreshers for experienced patients.
- Real-world patient videos in which parents and patients describe their experiences with using EpiPen® for first aid.
- Evidence-based information to help people understand more about anaphylaxis and their EpiPen® Auto-Injectors.
- Regular newsletters to keep patients up to date with relevant information.
- Evidence-based information to help people understand more about anaphylaxis and their EpiPen® Auto-Injectors, with links to ASCIA anaphylaxis resources, such as the EpiPen® version of the ASCIA Action Plan for Anaphylaxis.
- MyEpiPen® Welcome Kits which include the bag tag and wallet card that were developed by ASCIA after liaising with the team at Viatris.
To access MyEpiPen® go to https://www.myepipen.com.au/
Patients in New Zealand are currently on a separate EpiClub® NZ site, and will transition to MyEpiPen® in the near future.
ASCIA 2021 Virtual Conference registered delegates can attend the following Viatris sponsored sessions, as shown on page 10 of the ASCIA 2021 Conference Program Book https://ascia2021.com/program.php:
Thursday 2nd September, 9-9.45 AEST, ‘Risk Multipliers for Anaphylaxis’ presented by Prof Pete Smith.
Friday 3rd September 9-9.45 AEST, ‘Classic Hayfever, Local Allergic Rhinitis and Nasal Hyper-Reactivity: Sorting out Nasal Symptoms and Treatments’ presented by Prof Richard Harvey.
Register for the ASCIA 2021 Virtual Conference at https://ascia2021.com/registration.php